RVL Pharmaceuticals plc Interest Expense
RVL Pharmaceuticals plc reported Interest Expense of $13.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-08-14
- RVL Pharmaceuticals plc interest expense for the quarter ending 2023-06-30 was $13.00K, a 98.67% decline year-over-year.
- RVL Pharmaceuticals plc interest expense for the quarter ending 2023-03-31 was $26.00K, a 97.36% decline year-over-year.
- RVL Pharmaceuticals plc interest expense for the quarter ending 2022-12-31 was $15.00K, a 98.83% decline year-over-year.
- RVL Pharmaceuticals plc interest expense for the quarter ending 2022-09-30 was $1.13M, a 54.01% increase year-over-year.
- RVL Pharmaceuticals plc interest expense for fiscal 2022 was $3.11M, a 2.44% increase from fiscal 2021.
- RVL Pharmaceuticals plc interest expense for fiscal 2021 was $3.04M, a 25.86% decline from fiscal 2020.
- RVL Pharmaceuticals plc interest expense for fiscal 2020 was $4.09M.
- RVL Pharmaceuticals plc interest expense for fiscal 2018 was $20.79M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $13.00K 10-Q · filed 2023-08-14 | $39.00K 10-Q · filed 2023-08-14 | $54.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.19M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $26.00K 10-Q · filed 2023-05-11 | $41.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.17M derived: sum of 3 quarters · filed 2023-05-11 | $2.15M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $1.15M derived: sum of 2 quarters · filed 2023-03-20 | $2.13M derived: sum of 3 quarters · filed 2023-08-14 | $3.11M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $1.13M 10-Q · filed 2022-11-10 | $2.11M derived: sum of 2 quarters · filed 2023-08-14 | $3.10M 10-Q · filed 2022-11-10 | $4.38M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $978.00K 10-Q · filed 2023-08-14 | $1.96M 10-Q · filed 2023-08-14 | $3.25M derived: sum of 3 quarters · filed 2023-08-14 | $3.98M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $985.00K 10-Q · filed 2023-05-11 | $2.27M derived: sum of 2 quarters · filed 2023-05-11 | $3.01M derived: sum of 3 quarters · filed 2023-05-11 | $3.50M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.02M derived: sum of 2 quarters · filed 2023-03-20 | $2.52M derived: sum of 3 quarters · filed 2023-03-20 | $3.04M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $735.00K 10-Q · filed 2022-11-10 | $1.23M derived: sum of 2 quarters · filed 2022-11-10 | $1.75M 10-Q · filed 2022-11-10 | $2.29M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $494.00K 10-Q · filed 2022-08-11 | $1.01M 10-Q · filed 2022-08-11 | $1.55M derived: sum of 3 quarters · filed 2022-08-11 | $2.62M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $521.00K 10-Q · filed 2022-05-12 | $2.96M 10-Q · filed 2021-05-13 | $1.06M derived: sum of 2 quarters · filed 2022-05-12 | $2.13M derived: sum of 3 quarters · filed 2022-05-12 | $3.37M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.61M derived: sum of 2 quarters · filed 2022-03-30 | $2.85M derived: sum of 3 quarters · filed 2022-03-30 | $4.09M 10-K · filed 2022-03-30 | $14.40M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $1.07M 10-Q · filed 2021-11-15 | $3.56M 10-Q · filed 2020-11-10 | $2.31M derived: sum of 2 quarters · filed 2021-11-15 | $3.56M 10-Q · filed 2021-11-15 | $11.37M 10-Q · filed 2020-11-10 | -$1.17M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $1.24M 10-Q · filed 2021-08-16 | $3.74M 10-Q · filed 2020-08-11 | $2.49M 10-Q · filed 2021-08-16 | $7.80M 10-Q · filed 2020-08-11 | -$2.24M derived: sum of 3 quarters · filed 2021-09-08 | $2.27M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $4.06M 10-Q · filed 2021-05-13 | -$3.48M derived: sum of 2 quarters · filed 2021-09-08 | $1.03M derived: sum of 3 quarters · filed 2021-09-08 | $5.58M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$7.54M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$3.04M derived: sum of 2 quarters · filed 2021-09-08 | $1.51M derived: sum of 3 quarters · filed 2021-09-08 | $6.01M 8-K · filed 2021-09-08 | $18.21M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $4.50M 10-Q · filed 2020-11-10 | $4.50M 10-Q · filed 2019-11-14 | $9.06M derived: sum of 2 quarters · filed 2020-11-10 | $13.55M 10-Q · filed 2020-11-10 | $13.56M 10-Q · filed 2019-11-14 | $18.95M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $4.55M 10-Q · filed 2020-08-11 | $4.55M 10-Q · filed 2019-08-08 | $9.05M 10-Q · filed 2020-08-11 | $9.05M 10-Q · filed 2019-08-08 | $14.45M derived: sum of 3 quarters · filed 2020-08-11 | $19.76M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $4.50M 10-Q · filed 2020-05-12 | $4.50M 10-Q · filed 2019-05-09 | $9.90M derived: sum of 2 quarters · filed 2020-05-12 | $15.21M derived: sum of 3 quarters · filed 2020-05-12 | $20.45M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $10.71M derived: sum of 2 quarters · filed 2020-03-19 | $15.95M derived: sum of 3 quarters · filed 2020-03-19 | $20.79M 10-K · filed 2020-03-19 | $20.79M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $5.31M 10-Q · filed 2019-11-14 | $10.55M derived: sum of 2 quarters · filed 2019-11-14 | $15.40M 10-Q · filed 2019-11-14 | $22.73M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-06-30 | $5.24M 10-Q · filed 2019-08-08 | $10.08M 10-Q · filed 2019-08-08 | $17.42M derived: sum of 3 quarters · filed 2019-12-20 | $24.72M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-03-31 | $4.84M 10-Q · filed 2019-05-09 | $12.17M derived: sum of 2 quarters · filed 2019-12-20 | $19.48M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2017-12-31 | $7.33M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $14.63M derived: sum of 2 quarters · filed 2019-12-20 | $29.05M 8-K · filed 2019-12-20 | |||||
| 2017-09-30 | $7.30M 10-Q · filed 2018-11-08 | $21.72M 10-Q · filed 2018-11-08 |